Cancerwise - May 2010 archive | MD Anderson Cancer Center Skip to Content
Top

BY MD Anderson

The invention of IV Busulfex™ (the intravenous formulation of busulfan) has contributed to a dramatic change in the standard of care for patients undergoing stem cell transplantation for leukemia. It also has greatly improved the outlook for patients with hematologic (blood) and lymphoid cancers.

In March, the lead inventor, Borje S. Andersson, M.D., Ph.D., professor in MD Anderson's Department of Stem Cell Transplantation and...

BY Lana Maciel

In May 2003, Kenneth Woo was enjoying eight years of living cancer-free, having overcome his second bout with Hodgkin's disease in May 1995...

BY Andrew Lee, M.D.

No man wants to hear the sentence, "You have prostate cancer," but more than 190,000 men in the United States will be told that...

BY David Berkowitz

There's no gray area when it comes to MD Anderson's mission. For almost 70 years, it's been all about eliminating cancer in Texas, the nation and the world.

It's a mission that's easily understood by the thousands of employees and volunteers who roll up their sleeves to work here each day, and by nearly 800,000 patients who have placed their trust in our hands since 1944.

Now, for only the fourth time in the institution's...